/Investor DB

Carbon Silicon — Full Portfolio

11 tracked investments · listed companies and verified rows first

Ansa Biotechnologiesansabio.comin𝕏

Ansa provides an enzymatic DNA synthesis platform that directly synthesizes complex sequences up to 900 bp and delivers constructs up to 50 kb without assembly-based methods.

BiotechDeep TechHealthtechEmeryville, US

Dan Lin-Arlow(Founder)inSebastian Palluk(Founder)inDaniel Hillel Lin-Arlow(Executive Officer, Director)Jason T. Gammack(Executive Officer, Director)inDaniel Lin-Arlow(Founder)Jared Ellefson(Founder)

PartnerNish Bhat· solo GP

Co-investorsCerberus VenturesDauntless VenturesFifty YearsJude GomilaMetaplanetY Combinator+12 more

Basepairbasepairtech.comAug 2021

Basepair is a SaaS bioinformatics platform that provisions in a customer's own AWS account to store and analyze genomic and next-generation sequencing (NGS) data without moving it, offering point-and-click and API-driven workflows plus interactive visualization.

BiotechCloud ComputingData & InfrastructureNew York, US

Amit U Sinha(Founder)inAmit Sinha(Founder)

PartnerNish Bhat· solo GP

Co-investors37 AngelsDraper AssociatesEntrepreneurs Roundtable Accelerator (ERA)Fresco CapitalMetaplanetZ21 Ventures

Bluenotebluenotehealth.comin

Bluenote provides an AI platform for life sciences companies that automates the drafting of scientific and regulatory documents, workflow automation, and internal data search to speed up regulatory submissions.

AI & Machine LearningEnterprise SoftwareHealthtech

Fatima Sabar(Founder)in

PartnerNish Bhat· solo GP

Co-investorsElectric CapitalLux CapitalMcKesson VenturesMoxxie VenturesElad Gil

Current Surgicalcurrentsurgical.comin𝕏

Current Surgical develops a smart needle technology platform for surgical treatment of cancerous tumors.

Deep TechHealthtechMedical DevicesWashington, US

Al Mashal, Ph.D.(CEO / CoFounder)Chris Wagner, Ph.D.(CTO / CoFounder)

PartnerNish Bhat· solo GP

Co-investorsTrue VenturesDraper AssociatesSciFoundersMBX Capital

Femtofluidicsfemtofluidics.techin

FemtoFluidics is an early-stage company positioning around drug discovery, with a tagline referencing applying Moore's Law-style scaling to the field.

AI & Machine LearningBiotechDeep Tech

Zachary Xiong(Founder)in

PartnerNish Bhat· solo GP

Co-investorsGROOVE CAPITAL

Medramedra.aiin𝕏

Medra builds robotic systems integrated with AI, computer vision, and natural language processing to automate data collection for life science research.

AI & Machine LearningBiotechDeep TechRoboticsSan Francisco, US

Michelle Lee(Founder)inNat Friedman(Founder)inRussell Ohnemus(Founder)

PartnerNish Bhat· solo GP

Co-investors515 VenturesavraFifty YearsFusionHuman CapitalLux Capital+7 more

Octant Biooctant.bioin𝕏

Octant is a therapeutics company that develops small molecule drugs to treat protein misfolding diseases.

AI & Machine LearningBiotechDeep TechMedical DevicesEmeryville, US

Sri Kosuri(Founder)inRamsey Homsany(Founder)inRobert Andrade(Executive Officer, Director, Promoter)Maurice J. Costantini(Executive Officer, Director, Promoter)

PartnerNish Bhat· solo GP

Co-investorsAndreessen Horowitz+ND Capital8VCCatalio Capital Management, LPExplorer InvestmentsFifty Years+9 more

Olden Labsoldenlabs.com

PartnerNish Bhat· solo GP

Co-investorsCentre Street PartnersStartXTabula Rasa Ventures

Paralos Bioparalos.bioin

Paralos is developing a modular M13 phage drug delivery platform that creates phage-drug conjugates to concentrate therapeutic payloads at specific targets.

BiotechDeep Tech

PartnerNish Bhat· solo GP

Tetsuwan Scientifictetsuwan.cominDec 2024

Tetsuwan operates a cloud lab and automation platform called ResearchOS that lets researchers configure, simulate, and run biology experiments from their browser without physical lab access.

AI & Machine LearningBiotechRoboticsNew York, US

Cristian Ponce(CEO)inThéo Schäfer(Cofounder)in

PartnerNish Bhat· solo GP

Co-investors2048 VenturesEntrepreneur FirstEverywhere VenturesImpellent VenturesVolition Capital

Tomorrow Tastetomorrowtaste.com

Tomorrow Taste develops plant-based sweetener technology and beverages, creating protein-derived sweeteners for food and beverage manufacturers.

BiotechFoodTechNew Materials

PartnerNish Bhat· solo GP

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.